Guangzhou Xiangxue Pharmaceutical Co.,Ltd. Posted 58.4 Million Yuan Net Loss in First Half of 2023

Guangzhou Xiangxue Pharmaceutical Co.,Ltd. (广州市香雪制药股份有限公司) (300147.SZ) reported a net loss of 58.4 million yuan in the first half of 2023, narrowing 61.9% year-on-year.

Meanwhile, the company posted 1.2 billion yuan in revenue, up 0.9% year-on-year.

At the end of the reporting period, it had 9.2 billion yuan in total assets and 6.5 billion yuan in total liabilities, with a liability-to-asset ratio of 70.1%.